Year All20232022202120202019201820172016201520142013201220112009 Sep 26, 2023 REGENXBIO Announces Presentations at the 28th Annual Congress of the World Muscle Society Sep 05, 2023 REGENXBIO to Participate in Upcoming Investor Conferences Aug 30, 2023 Initial Clinical Data of First Pediatric CLN2 Patient Dosed with RGX-181 Presented at SSIEM Annual Symposium Aug 23, 2023 REGENXBIO Announces Presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2023 Aug 02, 2023 REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights Aug 01, 2023 REGENXBIO Announces Participation at the 2023 Wedbush PacGrow Healthcare Conference Jul 26, 2023 REGENXBIO to Host Conference Call on August 2 to Discuss Second Quarter 2023 Financial Results and Recent Operational Highlights
Sep 26, 2023 REGENXBIO Announces Presentations at the 28th Annual Congress of the World Muscle Society
Aug 30, 2023 Initial Clinical Data of First Pediatric CLN2 Patient Dosed with RGX-181 Presented at SSIEM Annual Symposium
Aug 23, 2023 REGENXBIO Announces Presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2023
Aug 02, 2023 REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights
Jul 26, 2023 REGENXBIO to Host Conference Call on August 2 to Discuss Second Quarter 2023 Financial Results and Recent Operational Highlights
